List of Tables
Table 1. Global Narcolepsy Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Narcolepsy Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Narcolepsy Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Narcolepsy Drug Sales by Region (2020-2025) & (K Units)
Table 5. Global Narcolepsy Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Narcolepsy Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Narcolepsy Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Narcolepsy Drug Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Narcolepsy Drug Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Narcolepsy Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Narcolepsy Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Narcolepsy Drug Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Narcolepsy Drug Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Narcolepsy Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Narcolepsy Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Narcolepsy Drug Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Narcolepsy Drug Sales Share by Manufacturer (2020-2025)
Table 18. Narcolepsy Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Narcolepsy Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Narcolepsy Drug Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Narcolepsy Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Narcolepsy Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Narcolepsy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Drug as of 2024)
Table 24. Narcolepsy Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Narcolepsy Drug Market
Table 26. Manufacturers Narcolepsy Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Jazz Pharmaceuticals Company Information
Table 29. Jazz Pharmaceuticals Description and Business Overview
Table 30. Jazz Pharmaceuticals Narcolepsy Drug Product
Table 31. Jazz Pharmaceuticals Narcolepsy Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Jazz Pharmaceuticals Sales Proportion of Narcolepsy Drug by Product in 2024
Table 33. Jazz Pharmaceuticals Sales Proportion of Narcolepsy Drug by Application in 2024
Table 34. Jazz Pharmaceuticals Sales Proportion of Narcolepsy Drug by Geographic Area in 2024
Table 35. Jazz Pharmaceuticals Recent Developments
Table 36. Teva Pharmaceutical Company Information
Table 37. Teva Pharmaceutical Description and Business Overview
Table 38. Teva Pharmaceutical Narcolepsy Drug Product
Table 39. Teva Pharmaceutical Narcolepsy Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Teva Pharmaceutical Sales Proportion of Narcolepsy Drug by Product in 2024
Table 41. Teva Pharmaceutical Sales Proportion of Narcolepsy Drug by Application in 2024
Table 42. Teva Pharmaceutical Sales Proportion of Narcolepsy Drug by Geographic Area in 2024
Table 43. Teva Pharmaceutical Recent Developments
Table 44. Novartis Company Information
Table 45. Novartis Description and Business Overview
Table 46. Novartis Narcolepsy Drug Product
Table 47. Novartis Narcolepsy Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Novartis Sales Proportion of Narcolepsy Drug by Product in 2024
Table 49. Novartis Sales Proportion of Narcolepsy Drug by Application in 2024
Table 50. Novartis Sales Proportion of Narcolepsy Drug by Geographic Area in 2024
Table 51. Novartis Recent Developments
Table 52. Mylan Company Information
Table 53. Mylan Description and Business Overview
Table 54. Mylan Narcolepsy Drug Product
Table 55. Mylan Narcolepsy Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Mylan Sales Proportion of Narcolepsy Drug by Product in 2024
Table 57. Mylan Sales Proportion of Narcolepsy Drug by Application in 2024
Table 58. Mylan Sales Proportion of Narcolepsy Drug by Geographic Area in 2024
Table 59. Mylan Recent Developments
Table 60. North America Narcolepsy Drug Sales by Country (2020-2025) & (K Units)
Table 61. North America Narcolepsy Drug Sales by Country (2026-2031) & (K Units)
Table 62. North America Narcolepsy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 63. North America Narcolepsy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 64. North America Narcolepsy Drug Sales by Type (2020-2025) & (K Units)
Table 65. North America Narcolepsy Drug Sales by Application (2020-2025) & (K Units)
Table 66. Asia-Pacific Narcolepsy Drug Sales by Region (2020-2025) & (K Units)
Table 67. Asia-Pacific Narcolepsy Drug Sales by Region (2026-2031) & (K Units)
Table 68. Asia-Pacific Narcolepsy Drug Revenue by Region (2020-2025) & (US$ Million)
Table 69. Asia-Pacific Narcolepsy Drug Revenue by Region (2026-2031) & (US$ Million)
Table 70. Asia-Pacific Narcolepsy Drug Sales by Type (2020-2025) & (K Units)
Table 71. Asia-Pacific Narcolepsy Drug Sales by Application (2020-2025) & (K Units)
Table 72. Europe Narcolepsy Drug Sales by Country (2020-2025) & (K Units)
Table 73. Europe Narcolepsy Drug Sales by Country (2026-2031) & (K Units)
Table 74. Europe Narcolepsy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 75. Europe Narcolepsy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 76. Europe Narcolepsy Drug Sales by Type (2020-2025) & (K Units)
Table 77. Europe Narcolepsy Drug Sales by Application (2020-2025) & (K Units)
Table 78. Latin America Narcolepsy Drug Sales by Country (2020-2025) & (K Units)
Table 79. Latin America Narcolepsy Drug Sales by Country (2026-2031) & (K Units)
Table 80. Latin America Narcolepsy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 81. Latin America Narcolepsy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 82. Latin America Narcolepsy Drug Sales by Type (2020-2025) & (K Units)
Table 83. Latin America Narcolepsy Drug Sales by Application (2020-2025) & (K Units)
Table 84. Middle East and Africa Narcolepsy Drug Sales by Country (2020-2025) & (K Units)
Table 85. Middle East and Africa Narcolepsy Drug Sales by Country (2026-2031) & (K Units)
Table 86. Middle East and Africa Narcolepsy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 87. Middle East and Africa Narcolepsy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 88. Middle East and Africa Narcolepsy Drug Sales by Type (2020-2025) & (K Units)
Table 89. Middle East and Africa Narcolepsy Drug Sales by Application (2020-2025) & (K Units)
Table 90. Narcolepsy Drug Key Raw Materials, Industry Status and Trend
Table 91. Narcolepsy Drug Key Raw Materials and Upstream Suppliers
Table 92. Narcolepsy Drug Clients Status and Trend
Table 93. Narcolepsy Drug Typical Clients
Table 94. Narcolepsy Drug Distributors
Table 95. Narcolepsy Drug Market Trends
Table 96. Narcolepsy Drug Market Drivers
Table 97. Narcolepsy Drug Market Challenges
Table 98. Narcolepsy Drug Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Narcolepsy Drug Product Picture
Figure 2. Global Narcolepsy Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Narcolepsy Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Antioxidants Type Product Picture
Figure 5. Stimulants Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Narcolepsy Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Narcolepsy Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Daytime Extreme Sleepiness
Figure 10. Cataplexia
Figure 11. Others
Figure 12. Narcolepsy Drug Report Years Considered
Figure 13. Global Narcolepsy Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Narcolepsy Drug Market Size 2020-2031 (US$ Million)
Figure 15. Global Narcolepsy Drug Sales 2020-2031 (K Units)
Figure 16. Global Narcolepsy Drug Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Narcolepsy Drug Revenue Market Share by Region (2020-2031)
Figure 18. Global Narcolepsy Drug Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Narcolepsy Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Narcolepsy Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Narcolepsy Drug Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Narcolepsy Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Narcolepsy Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 24. Antioxidants Type of Narcolepsy Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Stimulants Type of Narcolepsy Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Others of Narcolepsy Drug Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Narcolepsy Drug Sales Share by Manufacturer in 2024
Figure 28. Narcolepsy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Antioxidants Type Market Sales Proportion by Manufacturer in 2024
Figure 30. Stimulants Type Market Sales Proportion by Manufacturer in 2024
Figure 31. Others Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Narcolepsy Drug Revenue 2020-2031 (US$ Million)
Figure 33. North America Narcolepsy Drug Sales Market Share by Type (2020-2025)
Figure 34. North America Narcolepsy Drug Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Narcolepsy Drug Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Narcolepsy Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Narcolepsy Drug Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Narcolepsy Drug Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Narcolepsy Drug Sales Market Share by Application (2020-2025)
Figure 40. Europe Narcolepsy Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Narcolepsy Drug Sales Market Share by Country (2020-2031)
Figure 42. Europe Narcolepsy Drug Revenue Market Share by Country (2020-2031)
Figure 43. Europe Narcolepsy Drug Sales Market Share by Type (2020-2025)
Figure 44. Europe Narcolepsy Drug Sales Market Share by Application (2020-2025)
Figure 45. Latin America Narcolepsy Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Narcolepsy Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Narcolepsy Drug Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Narcolepsy Drug Sales Market Share by Type (2020-2025)
Figure 49. Latin America Narcolepsy Drug Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Narcolepsy Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Narcolepsy Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Narcolepsy Drug Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Narcolepsy Drug Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Narcolepsy Drug Sales Market Share by Application (2020-2025)
Figure 55. Narcolepsy Drug Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Narcolepsy Drug Raw Materials by Region in 2024
Figure 57. Narcolepsy Drug Distribution Channels
Figure 58. Global Narcolepsy Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Narcolepsy Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed